Cue Biopharma, Inc. Operating Leases, Future Minimum Payments, Due in Three Years
Cue Biopharma, Inc. (CUE) had Operating Leases, Future Minimum Payments, Due in Three Years of $2.86 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2022-11-14
- 2022-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.86M.
- 2022-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $2.74M.
- 2022-03-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.17M.
- 2021-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.00M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2022-09-30 | $2.86M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.74M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.17M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.00M 10-K · filed 2022-03-16 |
| 2018-12-31 | $1.43B 10-K · filed 2019-03-14 |
| 2018-09-30 | $4.91M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $3.97M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $4.66M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |